Skip to main content
Veterinary Medicines

Advantage 250 mg Lösung zum Auftropfen auf die Haut für Hunde

Authorised
  • Imidacloprid

Product identification

Medicine name:
Advantage 250 mg Lösung zum Auftropfen auf die Haut für Hunde
Advantage 250 mg Lösung zum Auftropfen auf die Haut für Hunde
Active substance:
  • Imidacloprid
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Imidacloprid
    250.00
    milligram(s)
    /
    2.50
    millilitre(s)
Pharmaceutical form:
  • Cutaneous solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX17
Authorisation status:
  • Valid
Authorised in:
  • Austria
Available in:
  • Austria
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinär Produkte GmbH
Responsible authority:
  • Austrian Agency For Health And Food Safety
Authorisation number:
  • 8-00326
Date of authorisation status change:
Reference member state:
  • Austria
Procedure number:
  • AT/V/0020/003
Concerned member states:
  • Denmark
  • Germany
  • Ireland
  • Italy
  • Netherlands
  • Norway
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 24/06/2021
Download
German (PDF)
Published on: 16/06/2020

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 16/06/2020

Labelling

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 16/06/2020

AT-puar-AT-V-0020-003-EN.pdf

English (PDF)
Published on: 31/08/2021
Download

AT-puar-AT-V-0020-003-DE.pdf

German (PDF)
Published on: 31/08/2021
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."